ArticleScientific reports2025
Development SPE-LC-MS/MS method for determination of WHO AWaRe Reserve antibiotics in hospital wastewater.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Overuse and inadequate legal regulation of the use of antibiotics have led to antimicrobial resistance, which threatens healthcare by reducing the effectiveness of treatments and promoting multidrug-resistant "superbugs". The World Health Organization created the AWaRe (Access, Watch, Reserve) classification to categorize antimicrobials according to their therapeutic value, emphasizing prudent use. The most important group in terms of protecting effectiveness is the Reserve group. The aim of the study was to develop a method for the determination of the following Reserve antibiotics in hospital wastewater: aztreonam, linezolid, meropenem, tigecycline, vaborbactam, cilastatin, fosfomycin, and ceftazidime. Twenty-six extraction procedures were tested and the one with the best recoveries for all antimicrobials (31.5-103.7%) was selected. The extracts were analyzed by liquid chromatography-tandem mass spectrometry. The method was validated and applied to the determination of the selected pharmaceuticals in effluents from 16 hospitals in Poland, with Reserve antibiotics detected in each sample at concentrations ranging from 1.89 ng L
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.